AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $7,102,000 | +486.5% | 206,146 | +184.3% | 0.00% | +300.0% |
Q2 2020 | $1,211,000 | +15.9% | 72,500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,045,000 | -98.5% | 72,500 | -96.5% | 0.00% | -97.4% |
Q4 2019 | $69,307,000 | +55.4% | 2,070,715 | -2.8% | 0.04% | +39.3% |
Q3 2019 | $44,608,000 | +1.0% | 2,130,261 | +0.4% | 0.03% | +3.7% |
Q2 2019 | $44,168,000 | -6.8% | 2,121,399 | +0.1% | 0.03% | -12.9% |
Q1 2019 | $47,370,000 | +1.8% | 2,119,475 | +8.9% | 0.03% | -11.4% |
Q4 2018 | $46,540,000 | -10.9% | 1,945,670 | +1.6% | 0.04% | +2.9% |
Q3 2018 | $52,260,000 | +27.5% | 1,915,689 | +25.7% | 0.03% | +17.2% |
Q2 2018 | $40,977,000 | -3.3% | 1,523,871 | +14.4% | 0.03% | -6.5% |
Q1 2018 | $42,396,000 | -19.9% | 1,331,941 | -4.9% | 0.03% | -18.4% |
Q4 2017 | $52,959,000 | +219.6% | 1,400,281 | +109.5% | 0.04% | +216.7% |
Q3 2017 | $16,568,000 | +15.6% | 668,354 | -4.2% | 0.01% | +9.1% |
Q2 2017 | $14,338,000 | -12.1% | 697,392 | -7.1% | 0.01% | -15.4% |
Q1 2017 | $16,311,000 | +11.4% | 750,640 | +4.9% | 0.01% | +8.3% |
Q4 2016 | $14,637,000 | +41.2% | 715,727 | +3.5% | 0.01% | +33.3% |
Q3 2016 | $10,369,000 | +29.1% | 691,242 | -6.9% | 0.01% | +28.6% |
Q2 2016 | $8,031,000 | -7.0% | 742,217 | +16.5% | 0.01% | 0.0% |
Q1 2016 | $8,637,000 | -30.7% | 636,971 | -5.6% | 0.01% | -36.4% |
Q4 2015 | $12,455,000 | -18.8% | 675,050 | +11.4% | 0.01% | -15.4% |
Q3 2015 | $15,345,000 | – | 606,029 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |